Pharmacokinetic assessment of constituents of Boswellia serrata, pine bark extracts, curcumin in combination including methylsulfonylmethane in healthy volunteers. (13th October 2019)

• Record Type: Journal Article
• Authors: Liu, Xiaoqian; Hunter, David J.; Eyles, Jillian; McLachlan, Andrew J.; Adiwidjaja, Jeffry; Eagles, Shane K.; Wang, XiaoSuo
• Is Part Of: Journal of pharmacy and pharmacology. Volume 72:Number 1(2020)
• Page Start: 121
• Page End: 131
• Publication Date: 2019-10-13
• Subjects: Boswellia serrata extract -- curcumin -- interaction -- pharmacokinetics -- pine bark extract; Pharmacy -- Periodicals; Pharmacology -- Periodicals; 615.1
• DOI: 10.1111/jphp.13184
• Languages: English
• ISSNs: 0022-3573

Abstract

Abstract: Objectives: Dietary supplements are increasingly used by people with osteoarthritis. Boswellia serrata extract, curcumin, pine bark extract and methylsulfonylmethane have been identified as having the largest effects for symptomatic relief in a systematic review. It is important to understand whether any pharmacokinetic interactions are among the major constituents of these supplements so as to provide information when considering the combination use of these supplements. The aim of this study was to investigate the pharmacokinetics of the constituents alone and in combination. Methods: This study was a randomized, open‐label, single‐dose, four‐treatment, four‐period, crossover study with 1‐week washout. The pharmacokinetics of the constituents of these supplements when dosed in combination with methylsulfonylmethane were compared to being administered alone. Plasma samples were obtained over 24 h from 16 healthy participants. Eight major constituents were analysed using a validated ultra‐high‐performance liquid chromatography–tandem mass spectrometry assay. Key findings: The pharmacokinetics of each constituent was characterized, and there were no significant differences in the pharmacokinetic profiles of the constituents when administered as a combination, relative to the constituents when administered alone ( P > 0.05). Conclusions: These data suggest that interactions between the major constituents of this supplement combination are unlikely and therefore could be investigated to manage patients with osteoarthritis without significant concerns for possible pharmacokinetic interactions.